ArticleTrials2022

Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus-a study protocol.

Noor Suleiman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.